BRPI0510148A - vacina para doença peridental - Google Patents

vacina para doença peridental

Info

Publication number
BRPI0510148A
BRPI0510148A BRPI0510148-4A BRPI0510148A BRPI0510148A BR PI0510148 A BRPI0510148 A BR PI0510148A BR PI0510148 A BRPI0510148 A BR PI0510148A BR PI0510148 A BRPI0510148 A BR PI0510148A
Authority
BR
Brazil
Prior art keywords
periodontal disease
vaccine
kits
detecting
treating
Prior art date
Application number
BRPI0510148-4A
Other languages
English (en)
Inventor
Kimberly Jean Dreier
John Morgan Hardham
John David Haworth
Kendall Wayne King
Rajendra Krishnan
David Ross Mcgavin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0510148A publication Critical patent/BRPI0510148A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

VACINA PARA DOENçA PERIDENTAL. A presente invenção refere-se aos novos isolados bacterianos identificados por seu DNA de rNA de 16S, que causam doença peridental em animais de companhia, seqüências de polinucleotídeo neles contidas, polipeptídeos codificados por tais seqüências de polinucleotídeo e vacinas compreendendo tais bactérias, polinucleotídeos ou polipeptídeos.Também fornecidos são métodos para tratar e prevenir doença peridental e kits para detectar e tratar kits de doença peridental para detectar e prevenir doença peridental. Além disso, métodos para avaliar a eficácia de uma vacina contra doenças peridentais em um animal são fornecidos.
BRPI0510148-4A 2004-05-21 2005-03-21 vacina para doença peridental BRPI0510148A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/851,965 US7378101B2 (en) 2001-12-21 2004-05-21 Vaccine for periodontal disease
PCT/IB2005/000822 WO2005112993A1 (en) 2004-05-21 2005-03-21 Vaccine for periodontal disease

Publications (1)

Publication Number Publication Date
BRPI0510148A true BRPI0510148A (pt) 2007-10-02

Family

ID=35058733

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510148-4A BRPI0510148A (pt) 2004-05-21 2005-03-21 vacina para doença peridental

Country Status (19)

Country Link
US (2) US7378101B2 (pt)
EP (1) EP1753454B1 (pt)
JP (1) JP4099213B2 (pt)
CN (1) CN101014363A (pt)
AR (1) AR048347A1 (pt)
AT (1) ATE432082T1 (pt)
AU (1) AU2005244663A1 (pt)
BR (1) BRPI0510148A (pt)
CA (1) CA2565925C (pt)
DE (1) DE602005014635D1 (pt)
ES (1) ES2325737T3 (pt)
IL (1) IL178971A0 (pt)
MX (1) MXPA06013471A (pt)
NO (1) NO20065064L (pt)
NZ (1) NZ550981A (pt)
RU (1) RU2364417C2 (pt)
TW (1) TW200538152A (pt)
WO (1) WO2005112993A1 (pt)
ZA (1) ZA200609105B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US7378101B2 (en) * 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US9181592B2 (en) * 2007-03-30 2015-11-10 Case Western Reserve University Method for detecting a bacterial pathogen
WO2008137506A2 (en) * 2007-05-01 2008-11-13 Mars Incorporated Methods and kits for dog plaque disease
JP2009173558A (ja) * 2008-01-22 2009-08-06 Gen Corp:Kk 抗イヌ歯周病組成物
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
BR112012005518B1 (pt) * 2009-09-10 2021-11-30 Merial, Inc Novas formulações de vacina compreendendo adjuvantes contendo saponina
BR112012012921A2 (pt) * 2009-12-01 2016-10-25 Intervet Int Bv uso de uma quantidade imunogênica de um vírus da doença de newcastle inativado e um adjuvante, composição farmacêutica, e, kit de partes
WO2012151272A2 (en) * 2011-05-02 2012-11-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
US20140335121A1 (en) * 2011-12-13 2014-11-13 School Corporation, Azabu Veterinary Medicine Educational Institution Fimbriae type of prophyromonas gulae
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
WO2015190589A1 (ja) * 2014-06-13 2015-12-17 学校法人麻布獣医学園 イヌの僧帽弁閉鎖不全症のリスク診断
JP2018154574A (ja) * 2017-03-16 2018-10-04 合同会社チューモス 点眼ワクチン及び免疫誘導方法
WO2019075260A1 (en) 2017-10-12 2019-04-18 Sutrovax, Inc. VACCINE AGAINST PERIODONTITIS AND ASSOCIATED COMPOSITIONS AND METHOD OF USE
EP3782633B1 (en) 2019-07-04 2024-03-27 Sosin Co., Ltd. Oral cavity composition for animals, and periodontal disease-preventing agent, infectious disease-preventing agent, and halitosis-preventing agent for animals
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN116751292B (zh) * 2023-07-31 2024-05-14 河南大学 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59128338A (ja) * 1982-12-08 1984-07-24 Kitasato Inst:The 歯周炎予防用ワクチン及びその製法
JPH0662431B2 (ja) 1984-12-14 1994-08-17 ライオン株式会社 歯周炎予防用経口ワクチン
US5536497A (en) * 1992-12-21 1996-07-16 The Research Foundation Of State University Of New York Fimbrial polypeptides useful in the prevention of periodontitis
JPH0797395A (ja) 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
WO1995010612A1 (fr) 1993-10-08 1995-04-20 Lion Corporation PROTEINE FIMBRILLINE DE $i(PORPHYROMONAS GINGIVALIS)
US5563063A (en) 1995-08-30 1996-10-08 Nihon University (Educational Foundation) Porphyromonas crevioricanis species of microorganism
US5710039A (en) 1995-08-30 1998-01-20 Nihon University (Educational Foundationn) Porphyromonas gingivicanis strain ATCC 55562
AUPQ137699A0 (en) * 1999-07-02 1999-07-22 University Of New England, The Control of acidosis
AUPQ718200A0 (en) 2000-04-28 2000-05-25 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
US7378101B2 (en) * 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease
US7468185B2 (en) * 2001-12-21 2008-12-23 Pfizer Inc. Vaccine for periodontal disease

Also Published As

Publication number Publication date
ATE432082T1 (de) 2009-06-15
ZA200609105B (en) 2008-12-31
MXPA06013471A (es) 2007-01-23
AU2005244663A1 (en) 2005-12-01
DE602005014635D1 (de) 2009-07-09
CA2565925C (en) 2011-01-18
TW200538152A (en) 2005-12-01
US7378101B2 (en) 2008-05-27
NZ550981A (en) 2009-07-31
ES2325737T3 (es) 2009-09-15
EP1753454B1 (en) 2009-05-27
EP1753454A1 (en) 2007-02-21
JP4099213B2 (ja) 2008-06-11
CN101014363A (zh) 2007-08-08
RU2364417C2 (ru) 2009-08-20
NO20065064L (no) 2006-12-01
AR048347A1 (es) 2006-04-19
US20080311151A1 (en) 2008-12-18
WO2005112993A1 (en) 2005-12-01
US20050010032A1 (en) 2005-01-13
JP2008500379A (ja) 2008-01-10
CA2565925A1 (en) 2005-12-01
RU2006140984A (ru) 2008-05-27
IL178971A0 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
BRPI0510148A (pt) vacina para doença peridental
BR0205775A (pt) Vacina para a doença periodontal
DE602006015665D1 (de) Probiotische enterokokken für eine verbesserte immunität
BRPI0615657A2 (pt) seqüência de nucleotìdeos que codificam proteìnas inseticidas
ITRM20050068A1 (it) Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine.
BRPI0407207A (pt) Método para tratar, prevenir e diagnosticar uma infecção por heliocobacter
ATE492639T1 (de) Multimer zur immunstimulation
EA201100413A1 (ru) Способ лечения бактериальной инфекции
EP2528931A4 (en) CYCLOVIRUS AND USE METHOD THEREFOR
WO2006046017A3 (en) Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter
NO20052956D0 (no) Defensinprotiner
MX2012003827A (es) Toxina rtx citolitica de gallibacterium anatis.
BRPI0520510A2 (pt) composições antimicrobiais e seus processos associados
ATE534902T1 (de) Replikationsproteinn ciz1
ATE442382T1 (de) Ein die mam-domäne enthaltendes protein
SI1565573T1 (sl) Sonde nukleinske kisline in primerji širokega območja iz regij v topoizomeraznih genih ter postopki, pri katerih jih uporabljamo
BRPI0607473A2 (pt) infecção por helicobacter em suìnos
BRPI0415742A (pt) vacina para a doença periodontal
DE602005020915D1 (de) Mannose-spezifische adhesinen und deren vervendung
DOP2006000117A (es) Terapia génica de interferon-beta usando un sistema mejorado de expresión regulada
KR20090047123A (ko) 꿀벌 유럽부저병 진단용 특이 프라이머 및 그 진단방법
ATE526400T1 (de) Metalloproteaseproteine
Dülger et al. Tracking the footsteps of Burkholderia mallei: determination of the molecular differences and potential resistance genes
WO2007108903A3 (en) Campylobacter vaccines and methods of use
Zidaric et al. International Clostridium difficile Animal Strain Collection

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.